257 related articles for article (PubMed ID: 1826699)
41. Transgene CD23 expression on lymphoid cells modulates IgE and IgG1 responses.
Texido G; Eibel H; Le Gros G; van der Putten H
J Immunol; 1994 Oct; 153(7):3028-42. PubMed ID: 8089484
[TBL] [Abstract][Full Text] [Related]
42. LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2R beta+ T cells.
Yoshimoto T; Nagai N; Ohkusu K; Ueda H; Okamura H; Nakanishi K
J Immunol; 1998 Aug; 161(3):1483-92. PubMed ID: 9686615
[TBL] [Abstract][Full Text] [Related]
43. Role of tumor-derived transforming growth factor-beta1 (TGF-beta1) in site-dependent tumorigenicity of murine ascitic lymphosarcoma.
Thakur VS; Shankar B; Chatterjee S; Premachandran S; Sainis KB
Cancer Immunol Immunother; 2005 Sep; 54(9):837-47. PubMed ID: 15726358
[TBL] [Abstract][Full Text] [Related]
44. Recipient polyclonal B cell activation and immunoglobulin production induced by priming with a retroviral superantigen.
Modlin CS; Muruve NA; Stanko D; Caulfield MJ; Fairchild RL
Cell Immunol; 1996 May; 169(2):252-63. PubMed ID: 8620553
[TBL] [Abstract][Full Text] [Related]
45. Mechanism for transforming growth factor beta and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures.
Lebman DA; Lee FD; Coffman RL
J Immunol; 1990 Feb; 144(3):952-9. PubMed ID: 2295822
[TBL] [Abstract][Full Text] [Related]
46. FcR epsilon+ lymphocytes and regulation of the IgE antibody system. II. FcR epsilon+ B lymphocytes initiate a cascade of cellular and molecular interactions that control FcR epsilon expression and IgE production.
Marcelletti JF; Katz DH
J Immunol; 1984 Dec; 133(6):2829-36. PubMed ID: 6238085
[TBL] [Abstract][Full Text] [Related]
47. Ontogeny and distribution of the murine B cell Fc gamma RII.
Foy TM; Lynch RG; Waldschmidt TJ
J Immunol; 1992 Sep; 149(5):1516-23. PubMed ID: 1387140
[TBL] [Abstract][Full Text] [Related]
48. No role of interleukin-4 in CD23/IgE-mediated enhancement of the murine antibody response in vivo.
Hjulström S; Landin A; Jansson L; Holmdahl R; Heyman B
Eur J Immunol; 1995 May; 25(5):1469-72. PubMed ID: 7774652
[TBL] [Abstract][Full Text] [Related]
49. Expression of the Fc gamma receptor on Ly-1+ B lymphocytes.
Dexter CM; Corley RB
Eur J Immunol; 1987 Jun; 17(6):867-71. PubMed ID: 2954830
[TBL] [Abstract][Full Text] [Related]
50. Bifidobacterium bifidum exhibits a lipopolysaccharide-like mitogenic activity for murine B lymphocytes.
Ko EJ; Goh JS; Lee BJ; Choi SH; Kim PH
J Dairy Sci; 1999 Sep; 82(9):1869-76. PubMed ID: 10509245
[TBL] [Abstract][Full Text] [Related]
51. Independent regulation of interleukin 4 (IL-4)-induced expression of human B cell surface CD23 and IgM: functional evidence for two IL-4 receptors.
Rigley KP; Thurstan SM; Callard RE
Int Immunol; 1991 Feb; 3(2):197-203. PubMed ID: 1709049
[TBL] [Abstract][Full Text] [Related]
52. Genesis of host IgE competence: perinatal IgE tolerance induced by IgE processed and presented by IgE Fc receptor (CD23)-bearing B cells.
Chen SS
Eur J Immunol; 1992 Feb; 22(2):343-8. PubMed ID: 1531635
[TBL] [Abstract][Full Text] [Related]
53. Surface immunoglobulin phenotype of complement receptor-positive and complement receptor-negative B cells of normal and xid immunodeficient mice.
Lindsten T; Finkelman FD; Thompson CB; Andersson B; Scher I
Eur J Immunol; 1984 Apr; 14(4):329-35. PubMed ID: 6609823
[TBL] [Abstract][Full Text] [Related]
54. Characterization of a spontaneous murine B cell leukemia (BCL1). I. Cell surface expression of IgM, IgD, Ia, and FcR.
Knapp MR; Jones PP; Black SJ; Vitetta ES; Slavin S; Strober S
J Immunol; 1979 Sep; 123(3):992-9. PubMed ID: 313960
[TBL] [Abstract][Full Text] [Related]
55. Relative expression of surface IgM, IgD and the Ig-associating alpha(mb-1) and beta(B-29) polypeptide chains.
Parkhouse RM; Preece G; Sutton R; Cordell JL; Mason DY
Immunology; 1992 Aug; 76(4):535-40. PubMed ID: 1398745
[TBL] [Abstract][Full Text] [Related]
56. Suppression of the humoral immune response by plasmacytomas: mediation by adherent mononuclear cells.
Kolb JP; Arrian S; Zolla-Pazner S
J Immunol; 1977 Feb; 118(2):702-9. PubMed ID: 138708
[TBL] [Abstract][Full Text] [Related]
57. Origin and fate of IgE-bearing lymphocytes. II. Gut-associated lymphoid tissue as sites of first appearance of IgE-bearing B lymphocytes and hapten-specific IgE antibody-forming cells in mice immunized with benzylpenicilloyl-keyhole limpet hemocyanin by various routes: relation to asialo GM1 ganglioside+ cells and IgE/CD23 immune complexes.
Auci DL; Chice SM; Heusser C; Athanassiades TJ; Durkin HG
J Immunol; 1992 Oct; 149(7):2241-8. PubMed ID: 1388186
[TBL] [Abstract][Full Text] [Related]
58. Loss of TGF-beta signaling contributes to autoimmune pancreatitis.
Hahm KB; Im YH; Lee C; Parks WT; Bang YJ; Green JE; Kim SJ
J Clin Invest; 2000 Apr; 105(8):1057-65. PubMed ID: 10772650
[TBL] [Abstract][Full Text] [Related]
59. Apoptosis of marginal zone B-cells in unimmunized mice.
Kishi Y; Tsubata T
J Med Dent Sci; 2009 Mar; 56(1):49-54. PubMed ID: 19697518
[TBL] [Abstract][Full Text] [Related]
60. B lymphocyte activation: entry into cell cycle is accompanied by decreased expression of IgD but not IgM.
Monroe JG; Havran WL; Cambier JC
Eur J Immunol; 1983 Mar; 13(3):208-13. PubMed ID: 6601015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
